Science


Posts filtered by tags: BioNtech[x]


 

Oxford Scientists Are Testing a Vaccine for the Plague

The scientists who developed one of the first widely available vaccines against covid-19 are now setting their sights on a long-time microscopic foe: the plague. This week, researchers at the University of Oxford in the UK announced the start of a Phase I clinical trial testing out a potential vaccine for the plague.…Read more...
Tags: UK, Science, Medicine, Astrazeneca, Pfizer, Vaccine, University of Oxford, Vaccines, Clinical Trials, Andrew Pollard, Moderna, BioNtech, Covid 19, Covid 19 Vaccine, Health Medical Pharma, Rna Vaccines


People Who Had Allergic Reaction to First Covid-19 Shot May Tolerate the Second Just Fine, Study Suggests

People who experienced a rare allergic reaction to the mRNA covid-19 vaccines may have less to worry about than feared, new research out Monday suggests. The study, which included several U.S. medical institutions, found that people who reported a reaction following their first dose were all able to safely take the…Read more...
Tags: Science, Medicine, Pfizer, Vaccines, Allergy, Clinical Trials, Johnson Johnson, Vanderbilt University, Moderna, Anaphylaxis, BioNtech, Respiratory Diseases, Clinical Medicine, Medical Specialties, Covid 19 Vaccine, Health Medical Pharma


How well COVID-19 vaccines work against the Delta variant, according to the best available data

A nurse at the Royal Cornwall Hospital prepares to administer a COVID-19 vaccine in Truro, United Kingdom. Hugh Hastings/Getty Images The Delta variant is the most common cause of new COVID-19 infections in the US, the UK, and elsewhere. Delta has mutations that can help it avoid the immune response. Four studies suggest vaccines from Pfizer, Moderna, and AstraZeneca work against Delta, to varying degrees. See more stories on Insider's business page. The highly-infectious Delta coronav...
Tags: Health, UK, Science, Scotland, India, Israel, US, Trends, Healthcare, Delta, Astrazeneca, Pfizer, Lancet, Variant, Stephen Evans, The World Health Organization


How well COVID-19 vaccines protect against the Delta variant, according to the best available data

A nurse at the Royal Cornwall Hospital prepares to administer a COVID-19 vaccine in Truro, United Kingdom. Hugh Hastings/Getty Images The Delta variant is the most common cause of new COVID-19 infections in the US, the UK, and elsewhere. Delta has mutations that can help it avoid the immune response. Four studies suggest vaccines from Pfizer, Moderna, and AstraZeneca work against Delta, to varying degrees. See more stories on Insider's business page. The highly-infectious Delta coronav...
Tags: Health, UK, Science, Scotland, India, Israel, US, Trends, Healthcare, Delta, Astrazeneca, Pfizer, Lancet, Variant, Stephen Evans, The World Health Organization


Covid-19 Vaccines Make Breakthrough Infections Shorter, Less Contagious: CDC Study

New research published this week is the latest to indicate that vaccinated people have much less to fear from covid-19. The study found that even in the rare cases when people given mRNA vaccines developed infections, they tended to experience shorter illness and produce less of the virus than unvaccinated people—both…Read more...
Tags: Health, Science, Medicine, Cdc, Virus, Pfizer, Vaccine, Virology, Clinical Trials, Johnson Johnson, Moderna, BioNtech, Medical Specialties, Zoonoses, Covid 19 Vaccine, Health Medical Pharma


CDC Stands by Masking Guidelines, Says Vaccinated Americans Are Safe From Delta Variant

The head of the Centers for Disease Control and Prevention, Rochelle Walensky, is trying to assuage vaccinated people’s fears about the Delta variant of the coronavirus. This morning, Walensky said that vaccinated people should remain protected from Delta and that they still didn’t need to wear masks in most…Read more...
Tags: Science, Medicine, Cdc, Delta, Vaccination, Astrazeneca, Health Care, Pfizer, Vaccine, Centers For Disease Control And Prevention, Biotechnology, Johnson Johnson, Moderna, BioNtech, Rochelle Walensky, Walensky


How Worried Should Vaccinated People Be About the Delta Variant?

The arrival of the Delta variant—the recently emerged strain of the coronavirus thought to be the most transmissible yet—in the U.S. is understandably unnerving scientists and the public alike. But how worried should you exactly be about Delta, especially if you’re fully vaccinated already?Read more...
Tags: Science, Medicine, Delta, Vaccination, Astrazeneca, Pfizer, Vaccine, Vaccines, Biotechnology, Clinical Trials, Johnson Johnson, B, BioNtech, Medical Specialties, Health Medical Pharma, Varicella Vaccine


How much protection you get from one dose of the Pfizer, AstraZeneca, and Moderna vaccines, according to the best available data

Pfizer's COVID-19 vaccine. Getty Millions of people worldwide have had one shot of two-dose COVID-19 vaccines. Pfizer and Moderna's vaccines are likely 80% effective against symptomatic COVID-19 after one dose. A single AstraZeneca shot is probably at least 70% effective at preventing symptomatic COVID-19. See more stories on Insider's business page. More than 179 million Americans and more than 44 million Britons have received their first dose of a two-shot COVID-19 vaccine.Th...
Tags: Health, UK, England, Science, India, Israel, US, Trends, Joe Biden, Data, South Africa, Healthcare, Food And Drug Administration, Brazil, Astrazeneca, Evans


Some experts who had Johnson & Johnson's single-dose vaccine are now getting extra shots of Pfizer or Moderna to try to protect against the Delta variant

A pharmacist at the Hartford Hospital in Hartford, Connecticut, fills a syringe with the Johnson & Johnson COVID-19 vaccine. Joseph Prezioso/Getty Images Some experts who got Johnson & Johnson's one-dose vaccine are topping it up with a dose of Pfizer or Moderna. They did it for extra protection against the fast-spreading Delta coronavirus variant, they said. The FDA and CDC don't recommend getting an extra shot, after a J&J vaccine or otherwise. See more stories on Insider's b...
Tags: Health, UK, Science, News, Cdc, US, Trends, Joe Biden, Healthcare, Delta, Astrazeneca, Fda, Pfizer, Vaccine, Johnson, Anthony Fauci


How Pfizer and BioNTech made history with their vaccine

Wondering how Pfizer and partner BioNTech developed a COVID-19 vaccine in record time without compromising safety? Dr Bill Gruber, SVP of Pfizer Vaccine Clinical Research and Development, explains the process from start to finish."I told my team, at first we were inspired by hope and now we're inspired by reality," Dr Gruber said. "If you bring critical science together, talented team members together, government, academia, industry, public health officials—you can achieve what was previously th...
Tags: Health, Science, Technology, Innovation, Fda, Pfizer, Vaccines, Gruber, Food and Drug Administration FDA, EUA, BioNtech, Bill Gruber, Pfizer Vaccine Clinical Research and Development


There's more evidence that getting both doses of Pfizer's vaccine may be 'critical' to protecting against emerging variants

Pfizer BioNTech COVID-19 vaccine Pete Bannan/MediaNews Group/Daily Local News via Getty Images Pfizer's vaccine worked against five coronavirus variants in the first lab study to directly compare them. It added more evidence that both doses may be needed to protect against emerging variants. Most people who get two doses would be protected against the variant initially from India, the researchers said. See more stories on Insider's business page. A leading UK expert has said it'...
Tags: Health, UK, Science, Cdc, India, US, Trends, South Africa, Healthcare, Delta, University of Bristol, Pfizer, Public Health England, Lancet, Finn, Variant


50% of U.S. Adults Will Be Fully Vaccinated by End of Today

The United States is at a pivotal point in its efforts to combat the covid-19 pandemic. By the end of Tuesday, it’s expected that a majority of American adults will be fully vaccinated, and within days, a majority of all Americans will have gotten at least one dose of a covid-19 vaccine. The accomplishment comes in…Read more...
Tags: Health, Science, Medicine, Medical Research, United States, Pfizer, Vaccine, Johnson Johnson, Moderna, BioNtech, Medical Specialties, Covid 19 Vaccine, Health Medical Pharma, Covid 19 Vaccination In The United States, Covid 19 Vaccination In Norway


The Pfizer and AstraZeneca COVID-19 vaccines are highly effective against the variant first found in India, but only if you get both doses, real-world data shows

On March 1, 2021, a woman receives a COVID-19 vaccine at a newly-opened vaccination site in Los Angeles, California. Al Seib / Los Angeles Times via Getty Images Pfizer and AstraZeneca's COVID-19 vaccines work against variants first found in India, real-world data shows. Pfizer's vaccine was 88% effective after two doses and AstraZeneca's was 60% effective against the variant, a UK study found. A single dose of Pfizer or AstraZeneca's vaccine was 33% effective, highlighting...
Tags: Health, UK, England, Science, News, India, US, Trends, Healthcare, Astrazeneca, Pfizer, Vaccine, Public Health England, Phe, Los Angeles California, London School of Hygiene and Tropical Medicine


A mix-and-match vaccine study suggests one shot of AstraZeneca followed by one shot of Pfizer is effective

Health personnel wear face masks outside the 12 de Octubre Hospital in Madrid, Spain, on March 10, 2020. Pablo Cuadra/Getty Images) Giving one shot of AstraZeneca's vaccine and then one dose of Pfizer's boosted antibodies, study found. The side-effects were similar to having two doses of the same vaccine, the scientists said. Some European countries have stopped using AstraZeneca's shot in people under 60, after safety concerns. See more stories on Insider's business page. ...
Tags: Science, France, Germany, Trends, Spain, Healthcare, Oxford, World Health Organization, Astrazeneca, Pfizer, Oxford University, Madrid Spain, Reuters, Carlos III Health Institute, Carlos III, BioNtech


The Pandemic Appears to Be Sputtering Out in the U.S.

The covid-19 pandemic is clearly and rapidly losing ground in the U.S. Daily new cases have continued to drop over the past few weeks, even as much of the country has begun to lift restrictions on distancing and mask-wearing. And while the vaccine rollout had slowed since its peak in April, it’s more recently picked…Read more...
Tags: Science, Medicine, Medical Research, Pfizer, Vaccine, Clinical Trials, BioNtech, Covid 19, Medical Specialties, Covid 19 Vaccine, Health Medical Pharma, Covid 19 Vaccines, Covid 19 Vaccination In Bulgaria, Covid 19 Vaccination In The United States, US Daily


Delaying a 2nd dose of Pfizer's vaccine by 9 weeks could boost antibodies to the virus, data suggests

Vera Leip, 88, receives a Pfizer-BioNtech COVID-19 vaccine at the John Knox Village Continuing Care Retirement Community on December 16, 2020 in Pompano Beach, Florida. Joe Raedle/Getty Images Delaying the second dose of Pfizer's COVID-19 vaccine could boost antibodies against coronavirus, a UK study suggests. The study tested a three-week gap between doses, as recommended by Pfizer, against a 12-week gap. The 12-week group produced three times as many antibodies. This doesn't nece...
Tags: Health, UK, Science, US, Trends, Joe Biden, Healthcare, Pfizer, Vaccine, Anthony Fauci, Phe, University of Edinburgh, University of Birmingham, Pompano Beach Florida, Public Health England PHE, Eleanor Riley


Five Ohio Residents to Get $1 Million Each Just for Getting Vaccinated in New Lottery

Five lucky people in Ohio will win $1 million each just for getting vaccinated for covid-19, Ohio Governor Mike DeWine announced on Wednesday. The new lottery, which starts handing out cash weekly on May 26, will be administered through the Ohio Department of Health as well as the Ohio Lottery and will be paid for…Read more...
Tags: Science, Ohio, Pfizer, Vaccine, Johnson Johnson, Mike DeWine, Ohio Lottery, DeWine, Ohio Department of Health, Moderna, BioNtech, Pfizer Vaccine, Covid 19 Vaccine, States Of The United States, Health Medical Pharma, State Government In The United States


Understanding SARS-COV-2 proteins is key to improve therapeutic options for COVID-19

Recently, the Oxford University and Pfizer and BioNTech made SARS-CoV-2 vaccines through targeting the spike protein gene. The US Food and Drug Administration (FDA) and the health authorities of the United Kingdom approved and started vaccination using the Pfizer and BioNTech mRNA vaccine. Also, The FDA of USA approved the treatment of COVID-19 using two monoclonal antibodies produced by Regeneron pharmaceuticals to target the spike protein.
Tags: Usa, Science, United Kingdom, Fda, Pfizer, Oxford University, US Food and Drug Administration FDA, Regeneron, BioNtech, COVID


One dose of Pfizer or AstraZeneca vaccine was highly effective at preventing coronavirus in older people, real-world data from South Korea suggests

Worshippers wearing face masks have their temperature taken as they attend a prayer ceremony entitled 'overcoming and healing the COVID-19 coronavirus', while marking Buddha's birthday at the Jo gye Buddhist temple in Seoul on April 30, 2020. ED JONES/AFP via Getty Images One dose of Pfizer or AstraZeneca vaccines was more than 86% effective at preventing COVID-19, data shows. South Korean health officials said Tuesday that more than 520,000 Koreans over 60 had had a single sho...
Tags: Health, South Korea, UK, Science, Scotland, Trends, Healthcare, Astrazeneca, Pfizer, Vaccine, Oxford University, Seoul, Lancet, Buddha, BioNtech, Coronavirus


Los Angeles County reported zero COVID-19 deaths for the 2nd day in a row

A COVID-19 warning sign in Los Angeles. Aydin Palabiyikoglu/Getty Images Los Angeles County reported no new COVID-19 deaths Monday for the second day in a row. It's the county's first time going two days without reporting a coronavirus death since March 2020. COVID-19 cases and deaths in the county have slowly been decreasing as vaccine efforts ramp up. See more stories on Insider's business page. Los Angeles County reported no new COVID-19 deaths for the second day in a row, c...
Tags: Science, California, Los Angeles, Trends, New York Times, Food And Drug Administration, Fda, Pfizer, Los Angeles County, Barbara Ferrer, BioNtech, Coronavirus, Lauren Frias, COVID-19, COVID


The CDC is warning states to remove COVID-19 vaccine-card templates as pro-Trump forums spread tips on how to forge the document

EJ Hersom, Department of Defense EJ Hersom, Department of Defense The CDC has told states to remove COVID-19 vaccine card templates to prevent forgery. Anti-vaxxer and pro-Trump forums have spread instructions on how to create the cards. The FBI has said forging the cards is illegal and it puts others in harm's way. See more stories on Insider's business page. The Centers for Disease Control and Prevention has warned states to remove COVID-19 vaccine card templates from their sites...
Tags: Facebook, Science, News, Nbc, Cdc, Nbc News, US, Trends, Joe Biden, Fbi, Healthcare, Pfizer, Vaccines, Donald Trump, Anthony Fauci, Centers For Disease Control And Prevention


One dose of Pfizer or AstraZeneca vaccine cuts COVID-19 spread by up to 50% within a household, a study found

Multi-generational household. Jae C. Hong/AP One dose of a Pfizer of AstraZeneca vaccine cut household transmission by up to 50% in a study. Protection kicked in from 14 days after vaccination regardless of age, Public Health England said. It remains unclear how long protection from one dose lasts for. See more stories on Insider's business page. A single dose of the Pfizer or AstraZeneca COVID-19 vaccine cut the spread of coronavirus within a household by up to 50% in a new study.Peop...
Tags: Health, UK, Science, Cdc, US, Trends, Healthcare, Astrazeneca, Pfizer, Transmission, Vaccine, University of Oxford, Public Health England, Phe, Jae, University of Surrey


How much protection you get from one shot of the Pfizer, AstraZeneca, and Moderna vaccines, according to the best available data

Pfizer's COVID-19 vaccine. Getty Millions of people worldwide have had one shot of two-dose COVID-19 vaccines. Pfizer and Moderna vaccines are likely 80% effective against symptomatic COVID-19 after one dose. A single AstraZeneca shot is probably at least 70% effective at preventing symptomatic COVID-19. See more stories on Insider's business page. More than 135 million Americans and more than 33 million Britons have received their first dose of a two-shot COVID-19 vaccine.The US h...
Tags: Health, UK, Science, US, Trends, Data, South Africa, Healthcare, Food And Drug Administration, Brazil, Astrazeneca, Evans, Fda, Pfizer, Vaccine, Oxford University


One dose of AstraZeneca or Pfizer's vaccine provides protection against COVID-19 that lasts at least 10 weeks

A nurse prepares to inject staff with the Pfizer/BioNtech covid-19 vaccine at Bradley Manor residential care home in Belfast on December 9, 2020. Liam McBurney/PA Images via Getty Images A single dose of Pfizer-BioNTech of AstraZeneca-Oxford University COVID-19 vaccine reduced infections by 65% in a UK survey of about 275,000 people. Effectiveness rose to 72% against COVID-19 with symptoms. Antibody responses lasted for up to 10 weeks for both vaccines, the study found. See more stories on...
Tags: Health, UK, Science, Scotland, Israel, Trends, Healthcare, Oxford, Astrazeneca, Belfast, Pfizer, Vaccine, Oxford University, Walker, Sarah Walker, Liam McBurney


One dose of the AstraZeneca or Pfizer vaccine provides protection against COVID-19 that lasts at least 10 weeks, study finds

A nurse preparing to inject staff members with the Pfizer-BioNTech COVID-19 vaccine at the Bradley Manor residential care home in Belfast, Northern Ireland, on December 9. Liam McBurney/PA Images via Getty Images One dose of a Pfizer-BioNTech or AstraZeneca-Oxford jab cut COVID-19 infections by 65% in a study. Effectiveness rose to 72% against COVID-19 with symptoms in the UK survey of about 375,000 people. Antibody responses lasted at least 10 weeks for both vaccines, the study found. See...
Tags: Health, UK, Science, Scotland, Israel, Trends, Healthcare, Oxford, Astrazeneca, Pfizer, Vaccine, Oxford University, Walker, Belfast Northern Ireland, Sarah Walker, Liam McBurney


One dose of the AstraZeneca or Pfizer vaccine provides protection against COVID-19 that lasts at least 10 weeks

A nurse preparing to inject staff members with the Pfizer-BioNTech COVID-19 vaccine at the Bradley Manor residential care home in Belfast, Northern Ireland, on December 9. Liam McBurney/PA Images via Getty Images One dose of a Pfizer-BioNTech or AstraZeneca-Oxford jab cut COVID-19 infections by 65% in a study. Effectiveness rose to 72% against COVID-19 with symptoms in the UK survey of about 275,000 people. Antibody responses lasted at least 10 weeks for both vaccines, the study found. See...
Tags: Health, UK, Science, Scotland, Israel, Trends, Healthcare, Oxford, Astrazeneca, Pfizer, Vaccine, Oxford University, Walker, Belfast Northern Ireland, Sarah Walker, Liam McBurney


The scientist behind Pfizer's vaccine says people will likely need a 3rd COVID-19 shot and yearly doses

MARK LENNIHAN/POOL/AFP/Getty The scientist behind Pfizer's COVID-19 vaccine said people will need a third dose. Dr. Özlem Türeci, BioNTech's chief medical officer, echoed comments from Pfizer CEO Albert Bourla. People would also likely need a yearly dose of the shot as immunity wanes, she said. See more stories on Insider's business page. People are likely going to need a third dose of the COVID-19 vaccine and then annual shots - similar to way things work during the seasonal ...
Tags: Science, News, Cdc, US, Trends, Joe Biden, Healthcare, Fda, Pfizer, Vaccine, Anthony Fauci, Flu Vaccine, Centers For Disease Control And Prevention, Cnbc, Johnson & Johnson, Mark Lennihan


What to Know About the Study Linking Covid-19 Vaccines and Shingles

New research purports to find a link between receiving an mRNA vaccine for covid-19 and shingles, also known as herpes zoster, in certain people with autoimmune conditions. But while the link may be worth exploring, the average person shouldn’t be worried about this possible risk or pay much attention to misleading…Read more...
Tags: Science, Medicine, Virus, Pfizer, Vaccine, Herpes Simplex, Shingles, BioNtech, Clinical Medicine, Chickenpox, Herpes Virus, Medical Specialties, Covid 19 Vaccine, Rna Vaccine, Health Medical Pharma, Victoria Furer


Covid-19 Booster Shots Likely Needed Within a Year, Top Biden Advisor Says

Booster shots against the covid-19 coronavirus may become a regular necessity, according to recent comments from David Kessler, chief science officer for President Joe Biden’s covid-19 task force, as well as from Pfizer CEO Albert Bourla. Read more...
Tags: Science, Medicine, Joe Biden, Medical Research, Vaccination, Pfizer, Vaccine, Anthony Fauci, Wall Street Journal, Clinical Trials, CVS Health, David Kessler, Moderna, Health Sciences, BioNtech, Albert Bourla


New data shows Moderna's vaccine remains highly protective 6 months after shots

A nurse administers a dose of the Moderna vaccine in Los Angeles, California. Mario Tama/Getty Images Moderna said Tuesday its vaccine was 90% effective in protecting people from COVID-19 six months after their shots. The results were on par with the long-term benefits of Pfizer's vaccine. A special booster shot developed for the B.1.351 variant out of South Africa is showing promising preclinical signs. See more stories on Insider's business page. Moderna's COVID-19 vaccine re...
Tags: Science, US, Trends, South Africa, Healthcare, Pfizer, Vaccine, Variant, Los Angeles California, Moderna, Stéphane Bancel, BioNtech, Coronavirus, COVID, Dispensed, Allison DeAngelis



Filters
show more filters
May - 2021
MoTuWeThFrSaSu
     12
3456789
10111213141516
17181920212223
24252627282930
31      
June - 2021
MoTuWeThFrSaSu
 123456
78910111213
14151617181920
21222324252627
282930    
July - 2021
MoTuWeThFrSaSu
   1234
567891011
12131415161718
19202122232425
262728293031